본문 바로가기
KERD
논문KCI 등재

암 환자에 대한 한국어판 FACIT-호흡곤란 10개 항목 단축형 설문지의 신뢰도와 타당도 분석

Reliability and Validity of Korean Version of FACIT-dyspnea 10 Item Short Form in Patients With Cancer

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류물리치료학

초록

Background: The Functional Assessment of Chronic Illness Therapy (FACIT) for Dyspnea was developed to assess multidimensional dyspnea using two subscales (experience of dyspnea and functional limitation) and a total score.Objects: This study aimed to assess the reliability and validity of the Korean version of the FACIT-dyspnea 10-item short form questionnaire (FACIT-dyspnea-K).Methods: Subjects were 163 patients with cancer. Dyspnea-related scales (modified Medical Research Council scale [mMRC], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 [EORTC QLQ-C30], Hospital Anxiety and Depression [HAD], and WHO Performance Scale) were used to validate the FACIT-dyspnea-K.Results: Internal consistency was confirmed by Cronbach’s alpha values of 0.90 and 0.95 in factors 1 and 2, respectively. Convergence validity was determined by comparing the two factors and total score of the FACIT-dyspnea-K with conceptually related assessment tools measuring the physical and emotional effects of dyspnea, with which correlations ranged from 0.364 to 0.567. Criterion validity was established by significant differences in the FACIT-dyspnea-K score between groups when the patients were classified by performance status as assessed by the WHO performance scale. Furthermore, the FACIT-dyspnea-K showed notable correlations with other dyspnea scales (mMRC, EORTC QLQ-C30, and HAD) for cancer patients (r = 0.28 to 0.54). The test-retest reliability of the two factors and total score of the FACIT-dyspnea-K appeared to be excellent (Cronbach’s alpha = 0.96 to 0.97).Conclusion: This study supports FACIT-dyspnea-K as a valid and reliable instrument to assess the dyspnea experience of cancer patients in clinical settings.

Abstract

Background: The Functional Assessment of Chronic Illness Therapy (FACIT) for Dyspnea was developed to assess multidimensional dyspnea using two subscales (experience of dyspnea and functional limitation) and a total score.Objects: This study aimed to assess the reliability and validity of the Korean version of the FACIT-dyspnea 10-item short form questionnaire (FACIT-dyspnea-K).Methods: Subjects were 163 patients with cancer. Dyspnea-related scales (modified Medical Research Council scale [mMRC], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 [EORTC QLQ-C30], Hospital Anxiety and Depression [HAD], and WHO Performance Scale) were used to validate the FACIT-dyspnea-K.Results: Internal consistency was confirmed by Cronbach’s alpha values of 0.90 and 0.95 in factors 1 and 2, respectively. Convergence validity was determined by comparing the two factors and total score of the FACIT-dyspnea-K with conceptually related assessment tools measuring the physical and emotional effects of dyspnea, with which correlations ranged from 0.364 to 0.567. Criterion validity was established by significant differences in the FACIT-dyspnea-K score between groups when the patients were classified by performance status as assessed by the WHO performance scale. Furthermore, the FACIT-dyspnea-K showed notable correlations with other dyspnea scales (mMRC, EORTC QLQ-C30, and HAD) for cancer patients (r = 0.28 to 0.54). The test-retest reliability of the two factors and total score of the FACIT-dyspnea-K appeared to be excellent (Cronbach’s alpha = 0.96 to 0.97).Conclusion: This study supports FACIT-dyspnea-K as a valid and reliable instrument to assess the dyspnea experience of cancer patients in clinical settings.

참고문헌 (23)

  1. American Thoracic Society, "Dyspnea. Mechanisms, assessment, and management: a consensus statement", Am J Respir Crit Care Med, 159(1), pp.321~340 (1999)
  2. Ander DS, "Measuring the dyspnea of decompensated heart failure with a visual analog scale : how much improvement is meaningful", Congest Heart Fail, 10(4), pp.188~191 (2004)
  3. Henoch I, "Validation of a Swedish version of the cancer dyspnea scale", J Pain Symptom Manage, 31(4), pp.353~361 (2006)
  4. Koelwyn GJ, "Exercise therapy in the management of dyspnea in patients with cancer", Curr Opin Support Palliat Care, 6(2), pp.129~137 (2012)
  5. Thomas JR, "Treatment of dyspnea in cancer patients", Oncology(Williston Park), 16(6), pp.745~750 (2002)
  6. van der Molen B, "Dyspnoea: a study of measurement instruments for the assessment of dyspnoea and their application for patients with advanced cancer", J Adv Nurs, 22(5), pp.948~956 (1995)
  7. Tanaka K, "Development and validation of the cancer dyspnoea scale:a multidimensional, brief, self-rating scale", Br J Cancer, 82(4), pp.800~805 (2000)
  8. Yount SE, "Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD)", Value Health, 14(2), pp.307~315 (2011)
  9. Hinchcliff ME, "Longitudinal evaluation of PROMIS-29and FACIT-dyspnea short forms in systemic sclerosis", J Rheumatol, 42(1), pp.64~72 (2015)
  10. Perez T, "INITIATIVES BPCO Scientific Committee. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease", Int J Chron Obstruct Pulmon Dis, 10, pp.1663~1672 (2015)
  11. Mahler DA, "Patient-reported dyspnea in COPD reliability and association with stage of disease", Chest, 136(6), pp.1473~1479 (2009)
  12. Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13(4), pp.863~868 (2004)
  13. Ayana BA, "Reliability and validity of amharic version of EORTC QLQ-C 30 questionnaire among gynecological cancer patients in Ethiopia", PLoS One, 11(6), pp.e0157359~ (2016)
  14. Oh SM, "A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups", J Korean Neuropsychiatr Assoc, 38(2), pp.289~296 (1999)
  15. Addy C, "Assessment of performance status in lung cancer-do oncologists and respiratory physicians agree", Lung Cancer, 75(Suppl 1), pp.S17~S18 (2012)
  16. Kline P, "The new psychometrics: science, psychology, and measurement", pp.53~ (1998), Routledge
  17. Marx RG, "A comparison of two time intervals for test-retest reliability of health status instruments", J Clin Epidemiol, 56(8), pp.730~735 (2003)
  18. Choi SW, "Development of a conceptual framework and calibrated item banks to measure patient-reported dyspnea severity and related functional limitations", Value Health, 14(2), pp.291~306 (2011)
  19. Rothstein JM, "Primer on measurement: an introductory guide to measurement issues", American Physical Therapy Association, ~ (1993)
  20. Fermanian J, "Measuring agreement between 2 observers:a quantitative case", Rev Epidemiol Sante Publique, 32(6), pp.408~413 (1984)
  21. Ferrer M, "Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group", Ann Intern Med, 127(12), pp.1072~1079 (1997)
  22. Bailey PH, "The dyspnea-anxiety-dyspnea cycle--COPD patients'stories of breathlessness: "it's scary", when you can't breathe", 2004, pp.14(6), 760~778
  23. Mahler DA, "Changes in dyspnea, health status, and lung function in chronic airway disease", Am J Respir Crit Care Med, 151(1), pp.61~65 (1995)

관련 논문AI추천

이 간행물의 다른 논문 (8건)